Mousseau, Yoanne <br/><br/>
Fingolimod potentiates the effects of sunitinib malate in a rat breast cancer model.  [electronic resource] 

 -  Breast cancer research and treatment  Jul 2012 
 - 31-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-011-1903-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Aorta, Thoracic--pathology<br/>Carcinoma 256, Walker--blood supply<br/>Cell Movement<br/>Cells, Cultured<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>Female<br/>Fingolimod Hydrochloride<br/>Indoles--administration & dosage<br/>Male<br/>Mammary Neoplasms, Experimental--blood supply<br/>Myocytes, Smooth Muscle--drug effects<br/>Neoplasm Transplantation<br/>Propylene Glycols--administration & dosage<br/>Proto-Oncogene Proteins c-sis--pharmacology<br/>Pyrroles--administration & dosage<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, Platelet-Derived Growth Factor beta--antagonists & inhibitors<br/>Receptors, Lysosphingolipid--metabolism<br/>Sphingosine--administration & dosage<br/>Sphingosine-1-Phosphate Receptors<br/>Statistics, Nonparametric<br/>Sunitinib<br/>Tumor Burden--drug effects<br/>Tyrphostins--pharmacology